- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT05120804
Fungování rodiny při léčbě obezity u mexických Američanů
Zlepšení fungování rodiny při léčbě obezity u mexických amerických žen
Mexican American families share similar elevated risks for obesity and obesity-related conditions, such as type 2 diabetes. Because negative family interactions and relationships (e.g., poor communication, high conflict, low emotional closeness) are associated with obesity treatment outcomes, this study tests a behavioral weight management intervention that provides relationship skills counseling to mothers and adult daughters. The goal is to improve family interaction patterns to buffer challenges and strengthen collaboration for eating and physical activity behaviors that support long-term weight management and thus provide an effective obesity treatment approach to address a major public health concern.
Přehled studie
Postavení
Podmínky
Detailní popis
Mexican American women are disproportionately affected by obesity and obesity-related conditions, such as type 2 diabetes. Obesity and diabetes are highly concordant in Mexican American families. Given the younger age of onset of diabetes in women with familial history, targeting mothers and their adult daughters for obesity treatment is warranted. From a family systems perspective, family-level approaches to obesity treatment can improve the adoption and maintenance of weight management behaviors. Including family members in treatment may also serve as a culturally salient intervention strategy as Mexican Americans endorse high level of familism. In contrast to traditional individual-level approaches to obesity treatment, a family-level approach grounded in familism would promote shared goals, collaborative problem solving, and communal coping when treating family members alongside each other. An important construct to consider when working with intergenerational Mexican American families is differences in acculturation, which may translate into differences in attitudes and behaviors. A wider gap in acculturation between parent and child has previously been associated with lower family functioning (e.g., poor communication, high conflict, low cohesion). However, interventions that promote bicultural competence by changing interactional patterns have been effective at improving family functioning. Hence, this study will conduct a randomized control trial testing the efficacy of a behavioral weight management intervention with brief and structured counseling on family functioning. Mexican American mothers and adult daughters (n=118 dyads) will be randomly assigned to receive standard behavioral treatment (SBT) or standard behavioral treatment plus relationship skills training (SBTR). Dyads participating in SBT or SBTR will attend 24 weekly sessions focused on nutrition and physical activity education along with behavior modification techniques. Dyads participating in SBTR will also receive experiential-based relationship skills training that draws from both general family systems concepts and behavioral family/couples therapy approaches to support familism, biculturalism, and communication competencies. The 12-month trial will consist of an intervention phase (1-6 months) and a maintenance phase (7-12 months). Assessments will be conducted at baseline and at the end of the intervention and maintenance phases. The primary outcome is weight loss. Secondary outcomes include treatment adherence (session attendance and self-monitoring records), physiological indicators of diabetes risk (hemoglobin A1c, waist circumference, and body fat percentage), health behaviors (eating and physical activity), psychological well-being (depression and perceived stress), and family functioning (subjective self-report and objective behavioral coding). Dyads in the SBTR group are expected to achieve greater improvements in primary and secondary outcomes than the STB group. Additionally, mediation by family functioning of intervention effects on primary and secondary outcomes will be examined.
Typ studie
Zápis (Odhadovaný)
Fáze
- Nelze použít
Kontakty a umístění
Studijní místa
-
-
California
-
La Jolla, California, Spojené státy, 92037
- University of California San Diego
-
La Jolla, California, Spojené státy, 93093
- University of California San Diego
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Popis
Inclusion Criteria:
- Female
- 18-65 years of age
- Mexican or Mexican American
- Reside in San Diego County
- Body mass index of 25-45 kg/m2
Exclusion Criteria:
- Unable to read and write in English or Spanish
- Pregnant or plan to become pregnant in the next year
- Have a physical limitation that makes exercise like walking difficult
- Currently participating in a weight loss program
- Underwent weight loss surgery
- Report a serious medical or psychological condition
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Léčba
- Přidělení: Randomizované
- Intervenční model: Paralelní přiřazení
- Maskování: Žádné (otevřený štítek)
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
|---|---|
|
Aktivní komparátor: Standard behavioral treatment
Nutrition and physical activity education along with behavior modification techniques |
Nutrition and physical activity education along with behavior modification techniques
Ostatní jména:
|
|
Experimentální: Standard behavioral treatment plus relationship skills training
Nutrition and physical activity education along with behavior modification techniques plus brief and structured counseling on family functioning |
Nutrition and physical activity education along with behavior modification techniques plus relationship skills training
Ostatní jména:
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Weight change
Časové okno: baseline to 6 month post-intervention
|
Weight loss |
baseline to 6 month post-intervention
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Weight change
Časové okno: 6 month post-intervention to 12 month follow-up
|
Weight loss maintenance |
6 month post-intervention to 12 month follow-up
|
|
Anthropometric measurement
Časové okno: baseline to 6 month post-intervention and 12 month follow-up
|
Percent body fat |
baseline to 6 month post-intervention and 12 month follow-up
|
|
Hemoglobin A1C
Časové okno: baseline to 6 month post-intervention and 12 month follow-up
|
Percent A1C |
baseline to 6 month post-intervention and 12 month follow-up
|
|
Family functioning
Časové okno: baseline to 6 month post-intervention and 12 month follow-up
|
Observational coding of family communication |
baseline to 6 month post-intervention and 12 month follow-up
|
|
Eating behavior
Časové okno: baseline to 6 month post-intervention and 12 month follow-up
|
Food frequency questionnaire |
baseline to 6 month post-intervention and 12 month follow-up
|
|
Physical activity
Časové okno: baseline to 6 month post-intervention and 12 month follow-up
|
Accelerometer |
baseline to 6 month post-intervention and 12 month follow-up
|
|
Psychosocial factors
Časové okno: baseline to 6 month post-intervention and 12 month follow-up
|
PHQ9 |
baseline to 6 month post-intervention and 12 month follow-up
|
Spolupracovníci a vyšetřovatelé
Sponzor
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Aktuální)
Primární dokončení (Odhadovaný)
Dokončení studie (Odhadovaný)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Aktuální)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Další relevantní podmínky MeSH
Další identifikační čísla studie
- 210620
Plán pro data jednotlivých účastníků (IPD)
Plánujete sdílet data jednotlivých účastníků (IPD)?
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Studuje produkt zařízení regulovaný americkým úřadem FDA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .